Acceptance of pharmacotherapy for relapse prevention by chronic alcoholics

Pharmacopsychiatry

Volumn 34, Issue 4, 2001, Pages 142-146

  Wetterling, T ^a,b   Veltrup, C ^b   Junghanns, K ^b   Kromer Olbrisch T ^c   Schneider, U ^c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; NALTREXONE;

ADULT; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; RELAPSE; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL DETERRENTS; ALCOHOLISM; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SELF-HELP GROUPS;

EID: 0034919424     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15874     Document Type: Article

References (25)

1. Techniques to enhance compliance with disulfiram
2. Combining pharmacological antagonists and behavioural psychotherapy in treating addictions
3. Evaluation of lithium therapy for alcoholism
4. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice
5. Drugs to decrease alcohol consumption in humans aversive agents
6. Pharmacotherapies for alcoholism: Promising agents and clinical issues
7. Pharmacotherapies for alcoholism: A review of research with focus on developments since 1991
8. Psychopharmaka
9. Measurement of compliance with naltrexone in the treatment of alcohol dependence: Research and clinical implications
10. Naltrexone and coping skills therapy for alcohol dependence
11. Psychotherapeutic considerations in pharmacological trials
12. Double-blind randomized multicentre trial of acamproste maintaining abstinende from alcohol
13. Lithium compliance in alcoholic males: A six month follow-up study
14. Some factors associated with compliance in the treatment of alcoholism
15. Health beliefs and compliance with alcoholism treatment
16. Relapse prevention by acamprosate
17. Alcohol patients' experience and attitudes on drug therapy for alcoholism
18. Naltrexone in the treatment of alcohol dependence
19. Naltrexone and alcohol dependence. Role of subject compliance
20. A new rating scale for the assessment of the Alcohol Withdrawal Syndrome (AWS-Scale) - As basis for a score controlled inpatient treatment
21. Medikamentöse Rückfallprophylaxe - Akzeptanz bei Alkoholkranken
22. Comparison of acamprosate and placebo in long-term treatments of alcohol dependence